Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to
Drug-induced nonautoimmune haemolytic anaemia
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6 | - | - |
| Unadjusted prevalence (%) | 0.00 | - | - |
| Mean age at first event (years) | 57.08 | - | - |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: D3_NONAIHA_DRUG – Drug-induced nonautoimmune haemolytic anaemia
GWS hits:
before Drug-induced nonautoimmune haemolytic anaemia
after Drug-induced nonautoimmune haemolytic anaemia
Loading survival analyses plot
Loading survival analyses table